Global X Aging Population ETF

Global X Aging Population ETF (AGNG) tracks the Indxx Aging Population Thematic Index, which picks drugmakers, medical device firms and senior housing companies in developed markets. Unlike most health care funds, it owns senior-living landlords such as Welltower and Ventas and spreads money fairly evenly: its 10 largest of 84 holdings were 32% of assets as of May 31, 2026. Its 0.50% expense ratio is above the 0.34% average of similar funds.

• Over the year to Oct 27, 2026, AGNG returned +13.3%, 9th of 9 among similar funds.
• Its 5-year annualized return was +6.4%.
• Its worst full calendar year was 2022 (-8.6%); its best was 2025 (+20.0%).
• The deepest fall in its price history was 25.7% (Sep 2, 2021 to Sep 27, 2022), recovered by Jul 10, 2024.

As of May 31, 2026, the fund held 84 securities; the ten largest made up 32.15% of assets.

• Over the three months to May 31, 2026, investors withdrew a net $64K (creations minus redemptions, per the N-PORT report).
• Monthly total returns reported for that quarter: 0.00%, -0.82%, -7.59%.

AGNG is an index fund. Its adviser, Global X Management Company LLC, part of Mirae Asset Global Investments, does not try to beat the Indxx Aging Population Thematic Index. It also does not move into cash when markets fall. Indxx starts with liquid stocks from developed markets, from the US and Europe to Japan and Australia. As of January 31, 2026, a company needed a market value of at least $500 million and average daily trading of at least $2 million over six months.

Indxx then looks for companies tied to four themes: health care products, health care services, medical devices and senior homes. A company qualifies if a large share of its revenue comes from these areas, or if its main business is focused on them. The index weights holdings by company size, with adjustments (a "modified" market-cap method). As of May 31, 2026, no holding was above 3.8%. The index is reshuffled and rebalanced once a year, and the fund's portfolio turnover was 9.93%.

The fund generally buys every stock in the index in about the same proportions. When that is impractical, it may hold a representative sample instead. It uses no leverage or derivatives. Because it owns Swiss, Japanese, Danish and other foreign shares, changes in exchange rates affect its value. The index and the fund's objective can change without a shareholder vote.

• AGNG charges 0.5% a year, versus an average of 0.34% for the similar funds below (7th of 9, cheapest first).
• Using the prospectus's standard example, $10,000 invested would cost about $51 in the first year and $628 over 10 years (assuming a 5% annual return).

It is a narrow, theme-based fund concentrated in pharmaceuticals, medical devices and senior housing, so it fits best as a small add-on to a broad core.

AGNG could add a focused bet on health care and senior housing alongside a broad stock fund. Its record covers few crises. It launched in 2016, so it has no 2008 history. It gained 19.28% in 2020. In 2022 it fell 21.7% between April 7 and September 27, and it took about 17 months, until February 15, 2024, to get back to its earlier high. Its worst calendar year was 2022, at -8.52%. Its deepest drop in price data starting April 2021 was 25.7%, and recovering from it took about 21 months. Selling shares during a stretch like that would lock in losses.

Income is small. The trailing yield was 0.86% as of October 27, 2026, paid twice a year. Under the SEC example, costs on $10,000 come to $51 after one year and $628 after 10 years. Past results don't predict the future, and a plan should look at the whole portfolio, not one fund.

Matched by holdings overlap from the latest N-PORT reports.